Biocon Q2 Results FY27: PAT Falls 51.12% to Rs 41.30 Cr, Revenue Rs 4,388.90 Cr

Biocon Ltd (BIOCON) Q2 Results FY27 announced on 4 November 2026, covering the company's financial performance for the July to September quarter. Revenue rose to Rs 4,388.90 Cr from Rs 4,295.50 Cr, while net profit, also called PAT, fell to Rs 41.30 Cr from Rs 84.50 Cr. The results date for this filing is 4 November 2026, and Biocon Q2 Results FY27 pair a revenue gain with a profit decline.

This results analysis from Univest covers the financial highlights, business drivers, outlook and risks behind Biocon Q2 Results, so the focus stays on Biocon's own revenue and net profit. The Financial Highlights table follows next.

Click Here – Get Free Investment Predictions

Biocon Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 4388.9 Cr	Rs 4295.5 Cr	+2.17% YoY
Net Profit (PAT)	Rs 41.3 Cr	Rs 84.5 Cr	-51.12% YoY

Source: company filing for Biocon Q2 Results FY27, 4 November 2026. Figures in Rs Crore.

Key Takeaways from Biocon Q2 Results: What Stands Out

• Revenue rose 2.17% YoY to Rs 4,388.90 Cr from Rs 4,295.50 Cr, showing modest top-line growth in the quarter.
• Net profit fell 51.12% to Rs 41.30 Cr from Rs 84.50 Cr, a decline that sits against the revenue gain.
• Biocon Q2 Results FY27 show diverging lines, with YoY growth in revenue and a sharp YoY decline in profit.
• Revenue was up 1.2% sequentially from Rs 4,336.00 Cr, a quarter-on-quarter move that sits beside the annual gain.
• Net profit margin narrowed to 0.9% from 2.0% in the comparison quarter, the main risk headline from this filing.
• The performance analysis comes next, tracing how revenue and net profit moved against each other.

Biocon Q2 Results FY27: Performance Analysis

Biocon posted revenue of Rs 4,388.90 Cr, up 2.17% YoY, and net profit of Rs 41.30 Cr, down 51.12% YoY. Revenue added Rs 93.40 Cr to the prior-year figure of Rs 4,295.50 Cr, while net profit gave up Rs 43.20 Cr from the earlier Rs 84.50 Cr.

Biocon Q2 Results FY27 place the two lines side by side, and the pattern is clear. A revenue gain of 2.17% did not carry profit, because net profit more than halved in rupee terms over the year. At Rs 41.30 Cr, net profit is about 0.9% of revenue, which matches the narrower margin in the filing.

For investors following the quarterly results, the supplied figures confirm what moved but do not by themselves establish the specific cause of the profit fall. Biocon Q2 Results therefore point readers to the disclosed drivers, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Year-on-Year Revenue Growth – The results analysis points first to revenue, which grew 2.2% year on year to Rs 4,388.90 Cr in the latest quarter. This is the top-line figure behind Biocon Q2 Results FY27 and the base against which profit is measured.

Sequential Revenue Growth – Revenue was up 1.2% quarter on quarter from Rs 4,336.00 Cr, so the quarterly results show growth over both the previous quarter and the same quarter last year, even as profit fell.

Revenue and Profit Divergence – Against revenue growth of 2.17% YoY, net profit declined 51.12% YoY, so the gap between the two lines is the defining feature of the quarter, and it leads straight into the FY27 outlook.

FY27 Outlook After Biocon Q2 Results

The outlook after Biocon Q2 Results rests on the quarters still to come, because full-year FY27 results will be built from the quarters that follow. This section limits itself to what the declared figures support and does not add management guidance.

Biocon Q2 Results FY27 give a revenue base of Rs 4,388.90 Cr and a net profit base of Rs 41.30 Cr to compare against in coming quarters. A results analysis on the Univest Screener can track how net profit moves relative to revenue, which brings the key risks into focus.

Key Risks to Watch After Biocon Q2 Results FY27

Net Profit Decline

Net profit fell 51.1% year on year to Rs 41.30 Cr. Biocon Q2 Results FY27 therefore carry the risk that profit keeps trailing revenue, since YoY growth in revenue alone did not offset the fall.

Narrower Net Profit Margin

Net profit margin narrowed to 0.9% from 2.0% in the comparison quarter, so a small change in revenue or costs can move profit sharply from this thinner base.

Low Return Ratios

Return on equity was low at 1.35% and return on capital employed was modest at 3.26% in FY26, ratios that investors may track alongside quarterly profit in the filings ahead.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Biocon Q2 Results FY27 show revenue of Rs 4,388.90 Cr, up 2.17% YoY, alongside net profit of Rs 41.30 Cr, down 51.12% YoY. These quarterly results, read with later filings, give investors facts to weigh, and Biocon Q2 Results should be assessed with a SEBI-registered advisor before acting.

Frequently Asked Questions on Biocon Q2 Results FY27

What are Biocon Q2 Results FY27?

Ans. Biocon Q2 Results FY27 cover the July to September 2026 quarter, with revenue of Rs 4,388.90 Cr and net profit of Rs 41.30 Cr, as the Quick Answer at the top of the article summarises.

What is the results date for Biocon Q2 Results FY27?

Ans. Biocon declared its quarterly results on 4 November 2026, which is the results date for this filing, and the Financial Highlights table sets the declared figures against the same quarter last year.

What revenue was reported in Biocon Q2 Results FY27?

Ans. Biocon reported revenue of Rs 4,388.90 Cr for Q2 FY27 against Rs 4,295.50 Cr a year earlier, which means revenue rose 2.17% and the Performance Analysis section covers this move.

What net profit was reported in Biocon Q2 Results FY27?

Ans. Biocon reported net profit of Rs 41.30 Cr in Q2 FY27 against Rs 84.50 Cr in the same quarter last year, so net profit fell 51.12% as the Key Takeaways section shows.

How much YoY growth did revenue show in Biocon Q2 Results FY27?

Ans. Biocon revenue showed YoY growth of 2.17% in Q2 FY27, moving from Rs 4,295.50 Cr to Rs 4,388.90 Cr, while the Key Business Factors section adds that revenue was up 1.2% on the previous quarter.

Did net profit rise or fall in Biocon Q2 Results?

Ans. Net profit fell in Biocon Q2 Results, dropping 51.12% YoY from Rs 84.50 Cr to Rs 41.30 Cr, which means the profit decline stands against the revenue rise covered in the Performance Analysis.

What was the net profit margin in Biocon Q2 Results FY27?

Ans. The net profit margin narrowed to 0.9% from 2.0% in the comparison quarter, which means less profit was kept from each rupee of revenue, a point raised again in the Key Risks section.

What was the prior-year net profit in Biocon Q2 Results?

Ans. The comparison quarter net profit was Rs 84.50 Cr, so Biocon Q2 Results show a lower figure of Rs 41.30 Cr this time, a gap that the Financial Highlights table sets out line by line.

What business factors shaped Biocon Q2 Results FY27?

Ans. The disclosed factors are the 2.2% YoY revenue gain to Rs 4,388.90 Cr and the 1.2% sequential rise from Rs 4,336.00 Cr, which together form the revenue story in Key Business Factors.

What are the key risks after Biocon Q2 Results FY27?

Ans. The risks flagged are the 51.1% YoY net profit fall to Rs 41.30 Cr and the narrower margin of 0.9%, while the FY26 return ratios of 1.35% and 3.26% add context in Key Risks.

What is the outlook after Biocon Q2 Results?

Ans. Full-year FY27 results will depend on the quarters that follow, so Biocon Q2 Results are one data point for the year, and the Outlook section lists what to track in later filings.

Where can I find the complete Biocon Q2 Results FY27 data?

Ans. The complete Biocon Q2 Results FY27 figures sit in the Financial Highlights table above, and the Univest Screener and Univest app carry the stock page where these quarterly results can be tracked over time.